Artificial intelligence in the risk prediction models of cardiovascular disease and development of an independent validation screening tool: a systematic review.

Abstract

Authors

• Yue Cai
  Department of Anesthesiology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
• Yu-Qing Cai
  China Medical University, Shenyang, 110122, China.
• Li-Ying Tang
  China Medical University, Shenyang, 110122, China.
• Yi-Han Wang
  China Medical University, Shenyang, 110122, China.
• Mengchun Gong
  Institute of Health Management, Southern Medical University, No. 1023-1063, Shatai South Road, Guangzhou 510515, People's Republic of China.
• Tian-Ci Jing
  Smart Hospital Management Department, the First Hospital of China Medical University, Shenyang, 110001, China.
• Hui-Jun Li
  State Key Laboratory of Natural Medicines, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing 210009, China. Electronic address: cpuli@163.com.
• Jesse Li-Ling
• Wei Hu
  State Key Laboratory for Novel Software Technology, Nanjing University, Nanjing, China.
• Zhihua Yin
  Department of Epidemiology, School of Public Health, China Medical University, Shenyang, 110122, China. zhyin@cmu.edu.cn.
• Da-Xin Gong
  Smart Hospital Management Department, the First Hospital of China Medical University, Shenyang, 110001, China. gongdx@cmu1h.com.
• Guang-Wei Zhang
  Smart Hospital Management Department, the First Hospital of China Medical University, Shenyang, 110001, China. gwzhang@cmu.edu.cn.

Keywords

External Resources